Bank Of America Corp Avalo Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.0 - $10.45 $11,118 - $38,727	-3,706 Reduced 98.62%	52 $0
Q1 2022 May 16, 2022	SELL	$7.57 - $21.72 $177,130 - $508,226	-23,399 Reduced 86.16%	3,758 $3,000
Q4 2021 Feb 08, 2022	SELL	$19.68 - $28.68 $386,967 - $563,934	-19,663 Reduced 42.0%	27,157 $46,000
Q3 2021 Nov 15, 2021	BUY	$26.16 - $40.68 $1.22 Million - $1.9 Million	46,820 New	46,820 $102,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $103M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.